Live Roundups Editor's Desk Insights Executive Ops Weather About 🔍
Home › Business & Finance › AstraZeneca should stick to its winning formula. It...
Business & Finance

AstraZeneca should stick to its winning formula. It doesn’t need a $400bn US mega-merger

The Guardian Business Monday 03 August 2026, 17:22 UTC By Nils Pratley 1 min read
Key Points

The Anglo-Swedish drugmaker’s flirtation with a grand combo with US group Bristol Myers Squibb is baffling• AstraZeneca shares fall 8.9% over merger talks with US cancer drug firmSir Pascal Soriot, chief executive of AstraZeneca, starts with huge credit in the bank, obviously. His long tenure has been a triumph, starting with the against-the-odds victory over Pfizer’s charmless accountants in 2014.The $39bn (£29bn) purchase of Alexion in 2021 looked a little over-priced at the time, but you...

The Anglo-Swedish drugmaker’s flirtation with a grand combo with US group Bristol Myers Squibb is baffling

• AstraZeneca shares fall 8.9% over merger talks with US cancer drug firm

Sir Pascal Soriot, chief executive of AstraZeneca, starts with huge credit in the bank, obviously. His long tenure has been a triumph, starting with the against-the-odds victory over Pfizer’s charmless accountants in 2014.

The $39bn (£29bn) purchase of Alexion in 2021 looked a little over-priced at the time, but you could see how it sat well with Soriot’s sermons on the importance of backing science. The deal got AZ into the field of medicines for rare diseases, which should offer decades of growth.

Continue reading...
AstraZeneca (ORG) US (LOCATION) Anglo (ORG) Bristol Myers Squibb (ORG) Pascal Soriot (ORG) Pfizer (ORG) Alexion (ORG) Soriot (PERSON) AZ (LOCATION)
Originally published by The Guardian Business Read original →

Related Stories

Sources: Padres finalizing trade for Giants' Ray

The San Diego Padres are finalizing a trade to acquire left-hander Robbie Ray from the San Francisco Giants, sources told ESPN's Jeff Passan on Monday. Ray, who is making $25 million in 2026 and will be a free agent after this season, has been one of the best pitchers in MLB since June and is 10-6 with a 3.08 ERA and 107 strikeouts this season. The Padres, while 11 games behind the Los Angeles Dodgers in the National League West, have gone 8-2 in their last 10 games and have surged back into...

ESPN just now

Trump says Exxon and Chevron made 'too much money' off high oil prices during Iran conflict: 'I don't like it'

US President Donald Trump speaks before signing an executive order in the Oval Office of the White House in Washington, DC on August 3, 2026. Jim Watson | Afp | Getty Images President Donald Trump said Monday that ExxonMobil and Chevron made too much money as crude oil prices rose due to the Iran war. "They're making too much money based on a shortage," Trump said.

CNBC 3m ago

Can Palantir pull off a Microsoft-style comeback? Here's what options say

Hopes are running high that high-profile software provider Palantir can shake off its nine-month bear market and rally after earnings Monday night. After all, the chart of Microsoft was looking similar going into its report, and that stock's now in the midst of a three-day, 25% bounce. The options flows around Palantir also mirror Microsoft going into its report, where traders were scooping up calls and betting on a bigger-than-usual swing.

CNBC 9m ago

Fundamentals In Korea Are Incredibly Strong: Taylor

Aug 3rd, 2026 Fundamentals In Korea Are Incredibly Strong: Taylor Sean Taylor, CIO and portfolio manager at Matthews, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." They discuss Mathews Korea Active ETF (ticker: MKOR). Aug 3rd, 2026 Fundamentals In Korea Are Incredibly Strong: Taylor Sean Taylor, CIO and portfolio manager at Matthews, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ."

Bloomberg Markets 10m ago